Navigation Links
Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Date:9/5/2007

bout Melanoma

Malignant melanoma is the most deadly form of skin cancer. The incidence of this disease is increasing by approximately 4% annually in the U.S. In 2004, the American Cancer Society estimates more than 55,000 cases of malignant melanoma will have been diagnosed. Melanoma is the number one cause of cancer death in women aged 25 to 29. More information about melanoma can be accessed at the Melanoma Research Foundation: http://www.melanoma.org.

About the EADO

The EADO is an international cooperative group dedicated to promote, coordinate and improve clinical and laboratory research activities in skin cancer. Further information about the EADO can be viewed at: http://www.eado.org/.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named- patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements wit
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
2. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
3. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
4. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
5. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
6. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
7. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
8. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Abaxis, Inc. (NasdaqGS: ABAX ), a ... reported financial results for the fourth quarter and fiscal ... and fiscal 2015 overview: , Revenues from continuing ... 33% over last year,s comparable quarter, and $202.6 million ... EPS of $0.50 for the fourth quarter, up 194% ...
(Date:4/30/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, May 7, 2015 to discuss ... Interested parties may access the live conference ...
(Date:4/30/2015)... JOLLA, Calif. , April 30, 2015   ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended March ... U.S. financial markets close. Regulus will ... 7, 2015, at 5:00 pm Eastern Daylight Time to ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
... June 16 The first in a planned series ... for millions of Indian cancer patients has been officially opened in ... and Fortis Healthcare, is equipped with advanced radiotherapy equipment and software ... , , ...
... Phytomedics Inc., a clinical stage biopharmaceutical company developing a novel portfolio of ... Dr. Laurie Smaldone , MD, President and Chief Executive Officer, will ... June 17th, 2010 , held at New York ,s Hotel ... , , ...
Cached Medicine Technology:Varian Medical Systems Equips International Oncology's First Comprehensive Cancer Center in India 2Varian Medical Systems Equips International Oncology's First Comprehensive Cancer Center in India 3Phytomedics Inc. to Present at 2010 New York Venture Summit 2
(Date:5/2/2015)... 02, 2015 Vancouver fencing company, QS Fencing, ... valuable advice to prospective clients related to their questions on ... install railings around their decks and patios. While that seems ... pop up once the person rolls up their sleeve to ... a railing in finding a gate that matches it. , ...
(Date:5/2/2015)... 2015 “ Peachtree Audio ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... , Music is an important part of people’s ... and given the royal treatment. Peachtree Audio does just ...
(Date:5/2/2015)... 2015 With the success that Veatch Dental ... to welcome Neida Miranda and Alex Shields to the team. ... over 41 years of combined experience working with dentists to ... dental field for 8 years. She was certified as ... Customer service, positive attitude and showing the importance of oral ...
(Date:5/1/2015)... ME (PRWEB) May 01, 2015 Royal ... in Freeport, Maine, reports on a new study that ... stiffness, joint swelling and improved physical function as well ... with severe osteoarthritis of the knee. , The report ... Natural Insights for Well Being® ,” which Royal River ...
(Date:5/1/2015)... Ernst & Young (EY) has announced ... & CSO, and Burak Sezen, Co-Founder & CTO of ... Entrepreneur Of The Year® 2015 Awards in the Ohio ... a global leader in assurance, tax, transaction and advisory ... the top audit companies in the world. The awards ...
Breaking Medicine News(10 mins):Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... is a strong predictor of coronary artery disease and mortality, ... that patients are nearly 60 percent at risk of having ... levels of abdominal aortic calcium, commonly known as plaque. High ... of dying, researchers say. Conversely, researchers found that ...
... the place of a good clinical exam, study finds , ... but 70 percent of able-bodied professional and collegiate hockey players ... , "This study was done to see if abnormal MRI ... Matthew Silvis, an assistant professor in the department of family ...
... exercise and proper nutrition, expert says , SUNDAY, March ... a large U.S. government-sponsored trial find that neither aggressive ... risk of heart events in people with type 2 ... a lot of people -- that this intensive blood ...
... ... benefits of acupuncture, hypnosis and neuroprogramming without the expense and inconvenience of sitting in doctors ... , ... March 14, 2010 -- AcuAids announces acupuncture at home to stop smoking, lose weight and ...
... Skin ailment boosts odds for heart attack, stroke, and ... 13 (HealthDay News) -- The common skin ailment psoriasis ... other cardiovascular woes, probably through a shared inflammatory response, ... evidence for psoriasis as a risk factor for cardiovascular ...
... attack, even death, study suggests , SATURDAY, March 13 (HealthDay ... for the heart, then turbo-charged workouts like training for marathons ... according to new research by Greek doctors who found that ... that some types of high-intensity exercise may actually be bad ...
Cached Medicine News:Health News:Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes 2Health News:Scans May Be Misleading for Hockey Players 2Health News:Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics 2Health News:Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics 3Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 2Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 3Health News:Psoriasis Tied to Raised Heart Risk 2Health News:Marathoners Face Greater Risk of Artery Stiffness 2
... incubators is available, ensuring the customers to ... specific requirements. miniTHERM incubators have a capacity ... space saving. Their size corresponds approximately to ... to stack up to three units on ...
... the leading name in high ... for more than 15 years. ... brought leading edge technology, such ... sensors,microprocessor control, directed airflow, and ...
... The Dual Media Set, different from commonly ... (LB) or other specially prepared medium, contains ... BROTH (OB). For cell expansion, E. coli ... production of the recombinant protein is almost ...
Listeria Enrichment Broth...
Medicine Products: